Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Experience the Future of Eye Care: Oculis, a Clinical Biopharmaceutical Innovator, Pioneering Breakthrough Treatments for Ophthalmic Diseases & Transforming Lives Globally.

News

Blog 13 days ago
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
The post Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities appeared first on Oculis.
Read more
Report
Blog 30 days ago
Oculis' Pioneer Program: Optic Neuritis as a Proof of Concept for Retinal Neuroprotection
The post Oculis' Pioneer Program: Optic Neuritis as a Proof of Concept for Retinal Neuroprotection appeared first on Oculis.
Read more
Report
Blog 1 month ago
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
The post First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis appeared first on Oculis.
Read more
Report
News FinanzNachrichten.de 1 month ago
Oculis Holding AG: First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
The PIONEER program marks a key step toward potential first-in-class neuroprotection for optic neuritis and other neurological diseases, supported by positive Acuity Phase 2 data, FDA Breakthrough Therapy
Read more
Report
Pro access
Upgrade to see all 17 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.